HYPERKALEMIA

This study is testing an oral medication called WS016 to see if it can safely and effectively lower and control high potassium levels in adults. The trial has two main parts: a short 2-day phase to quickly reduce potassium, followed by a 28-day phase to maintain normal levels. Pa…

This study aims to see if providing doctors and patients with better training and standardized care plans can improve how high potassium levels are managed in people with chronic kidney disease. It will enroll 1,000 adult patients in China who have kidney disease and high potassi…

This study is testing a medication called patiromer in children under 12 who have high potassium levels, a condition called hyperkalemia. The main goals are to see if the drug safely lowers potassium and to check for side effects. It will involve about 32 children and is designed…

This study is testing if adding a small amount of urea (a natural waste product) to the dialysis fluid can prevent a dangerous brain swelling condition in kidney failure patients. These patients need urgent dialysis to fix life-threatening potassium or acid levels, but rapid trea…

This study is testing whether people with chronic kidney disease can safely eat more potassium-rich fruits and vegetables. Researchers will provide 30 participants with home-delivered produce that is either high or low in potassium for six weeks each, then switch. The goal is to …

This study is testing if a drug called patiromer can help people with moderate to severe chronic kidney disease safely take higher doses of a common kidney-protecting blood pressure medication (irbesartan). In this 44-person trial, participants will try both patiromer and a place…

This study is testing a new smartphone app called AK+ Guard™ that aims to detect dangerously high potassium levels in people with chronic kidney disease. The app analyzes a simple, one-lead heart rhythm reading, which can be taken with devices like an Apple Watch. Researchers wan…